Keros Therapeutics Announces Review of Strategic Alternatives
Go back to Keros Therapeutics Announces Review of Strategic Alternatives| (NASDAQ: KROS) | Delayed: 11.23 +0.16 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.07 | 52 Week High | $ | |||
| Open | $11.07 | 52 Week Low | $ | |||
| Day High | $11.49 | P/E | N/A | |||
| Day Low | $10.97 | EPS | $ | |||
| Volume | 97,937 | |||||

